Coronavirus: Information & Resources

Johnson & Johnson Update | April 13, 2021

Today the CDC and the state of Colorado Department of Public Health & Environment (CDPHE) recommended a pause in the distribution of the Johnson & Johnson (Janssen) vaccine pending further review. The CDC and the FDA are reviewing recent data involving six reported cases in the U.S. of a rare and severe type of blood clot in women who received the Johnson & Johnson (Janssen) vaccine. Right now they advise that these adverse events are extremely rare, but are taking a highly cautious approach while they further assess the data.

National Jewish Health has paused administering the Johnson & Johnson (Janssen) COVID-19 Vaccine until we receive further guidance from the CDC and CDPHE.

If you have received the Johnson & Johnson (Janssen) vaccine in the past three weeks and feel you may be experiencing symptoms (severe headache, abdominal pain, leg pain, or shortness of breath) within three weeks of vaccination, please contact your health care provider. If your symptoms are severe, please call 911 or go to an emergency room.

For more information, visit the Joint CDC and FDA statement on Johnson & Johnson COVID-19 Vaccine.

Learn more about COVID-19 Vaccine Distribution at National Jewish Health.

Expanded Patient Care & Testing

National Jewish Health is committed to your safety and continued health during this challenging time. It is important that you continue to care for your chronic lung, heart or immunological health issues and we have a strong plan in place to ensure that we can safely provide care to our patients.

Treatment, testing and recovery appointments for adult and pediatric patients are available in our Respiratory Recovery Clinics and Acute Respiratory Clinics. Patients see dedicated experts in isolated areas, and receive COVID-19 testing as needed. Both new and current patients are welcome by appointment; same day or next day appointments are available.

Please call 303.398.1355 or make a physician appointment online.